Shire applies to test haemophilia A gene therapy in humans – PharmaTimes
|
Shire applies to test haemophilia A gene therapy in humans
PharmaTimes Shire has submitted a request to the US Food and Drug Administration to test its investigational factor VIII (FVIII) gene therapy SHP654 in patients with the bleeding disorder haemophilia A. SHP654 (also known as BAX 888) aims to protect haemophilia A … |
